Sponsor Pipeline

Climb Bio, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07564596
A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)		 Recruitment opened
2026-07-31 NCT07090655
A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal…		 Trial completed
2026-07-31 NCT07090655
A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal…		 Enrollment reduced: 38 -> 30 participants
2026-07-31 NCT07090655
A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal…		 date change Completion moved earlier: 2026-06 -> 2026-04-07
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07096843 A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy Primary Membranous Nephropathy Recruiting
Phase 1/2
NCT07043946 A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) Immune Thrombocytopenia (ITP) Recruiting
NCT07564596 A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) Systemic Lupus Erthematosus Recruiting
Phase 1
NCT07248865 A Phase 1 Study of CLYM116 in Normal Healthy Volunteers Healthy Volunteers Recruiting
NCT07011043 A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus Recruiting
Disease Areas
Lupus (SLE) (2)
Get alerts when Climb Bio, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free